EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 21 / Numéro 3 (Mars 2005) Med Sci (Paris), 21 3 (2005) 315-319 Références
Accès gratuit
Numéro
Med Sci (Paris)
Volume 21, Numéro 3, Mars 2005
Page(s) 315 - 319
Section M/S revues
DOI https://doi.org/10.1051/medsci/2005213315
Publié en ligne 15 mars 2005
  1. Wolf S. The pharmacology of placebos. Pharmacol Rev 1959; 11 : 689–704. [Google Scholar]
  2. Shapiro AK, Shapiro E. The placebo : is it much ado about nothing. In : Harrington A, ed. The placebo effect : an interdisciplinary exploration. Cambridge : Harvard University Press, 1997 : 2–36. [Google Scholar]
  3. Lemoine P. Le mystère du placebo. Paris : Odile Jacob, 1996 : 238 p. [Google Scholar]
  4. Beecher HK. The powerful placebo. JAMA 1955; 159 : 1602–6. [Google Scholar]
  5. Turner JA, Deyo RA, Loeser JD, et al. The importance of placebo effects in pain treatment and research. JAMA 1994; 271 : 1609–14. [Google Scholar]
  6. Hrobjartsson A, Gotzsche PC. Is the placebo powerless ? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001; 344 : 1594–602. [Google Scholar]
  7. De la Fuente-Fernandez R, Schulzer M, Jon Stoessl A. The placebo effect in neurological disorders. Lancet Neurol 2002; 1 : 85–91. [Google Scholar]
  8. Evans FJ. Expectancy, therapeutic instructions and placebo responses. In : Placebo : theory, research and mechanisms. New York : Guilford Press, 1985 : 215–28. [Google Scholar]
  9. Flaten MA, Simonsen T, Olsen H. Drug related information generates placebo and nocebo responses that modify the drug response. Psychosom Med 1999; 61 : 250–5. [Google Scholar]
  10. Kirsch I. Specifying non-specific : psychological mechanism of the placebo effect. In : Harrington A, ed. The placebo effect : an interdisciplinary exploration. Cambridge : Harvard University Press, 1997 : 166–86. [Google Scholar]
  11. Ader R, Cohen N. Behaviorally conditioned immunosuppression and murine systemic lupus erythematous. Science 1982; 215 : 1534–6. [Google Scholar]
  12. Ader R. The role of conditioning in pharmacotherapy. In : Harrington A, ed. The placebo effect : an interdisciplinary exploration. Cambridge : Harvard University Press, 1997 : 138–65. [Google Scholar]
  13. Enserink M. Can the placebo be the cure ? Science 1999; 184 : 238–40. [Google Scholar]
  14. Haour F, Marquette C, Ban E, et al. Interleukin-1 receptors in the central nervous system : role in infection and stress. J Psychiatr Neurosci 1995; 20 : 357–63. [Google Scholar]
  15. Haour F, Dicou E. Interleukin-1 receptors and ligands in the nervous system. In : Saade NE, et al., eds. Pain and neuroimmune interactions. New York : Kluger Academic-Plenum Publisher, 2000 : 157–70. [Google Scholar]
  16. Besedovsky H, Del Rey AE. Immune-neuro-endocrine interactions : facts and hypotheses. Endocrinol Rev 1996; 17 : 64–102. [Google Scholar]
  17. Blalock JE. The syntax of immune-neuroendocrine communication. Immunol Today 1994; 15 : 504–11. [Google Scholar]
  18. Pert CB, Ruff MR, Weber RJ, et al. Neuropeptides and their receptors : a psychosomatic network. J Immunol 1985; 135 : S820–6. [Google Scholar]
  19. Dunn AJ. Mechanisms by which cytokines signal the brain. Int Rev Neurobiol 2002; 52 : 43–65. [Google Scholar]
  20. Goebel MU, Trebst AE, Steiner J, et al. Behavioral conditioning of immunosuppression is possible in humans. FASEB J 2002; 16 : 1869–73. [Google Scholar]
  21. De la Fuente-Fernandez R, Ruth TJ, Sossi V, et al. Expectation and dopamine release : mechanism of the placebo effect in Parkinson’s disease. Science 2001; 293 : 1164–6. [Google Scholar]
  22. De la Fuente-Fernandez R, Jon Stoessl A. The placebo effect in Parkinson’s disease. Trends Neurosci 2002; 25 : 302–6. [Google Scholar]
  23. Kaasinen V, Aalto S, Nägren K, Rinne JO. Expectation of caffeine induces dopaminergic responses in humans. Eur J Neurosci 2004; 19 : 2352–6. [Google Scholar]
  24. Wall PD. The placebo and the placebo response. In : Wall PD, Melzack R, eds. Textbook of pain. New York : Churchill Livingston, 1993 : 1297–308. [Google Scholar]
  25. Exton MS, Schult M, Donath S, et al. Behavioral conditionning prolongs heart allograft survival in rats. Transplant Proc 1998; 30 : 2033. [Google Scholar]
  26. Exton MS, Schult M, Donath S, et al. Conditionned immunosuppression make subtherapeutic cyclosporine effective via splenic innervation. Am J Physiol 1999; 276 : 1710–7. [Google Scholar]
  27. Exton MS, Gierse C, Meier B, et al. Behaviouraly conditioned immunosuppression in the rat is regulated by noradrenaline and beta-adrenoreceptors. J Neuroimmunol 2002; 131 : 21–30. [Google Scholar]
  28. Wolf S. Effect of suggestion and conditioning on the action of the chemical agents in human subjects. The pharmacology of placebos. J Clin Invest 1950; 29 : 100–9. [Google Scholar]
  29. Stockhorst U, Mahl N, Krueger M, et al. Classical conditioning and conditionability of insulin and glucose effect in healthy humans. Physiol Behav 2004; 81 : 375–88. [Google Scholar]
  30. Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia : expectation-activated opioid systems versus conditionning-activated specific subsystems. J Neurosci 1999; 19 : 484–94. [Google Scholar]
  31. Bootzin RR. The role of expectancy in behavior change. In : Placebo, theory, research, and mechanisms. New York : Guilford Press, 1985 : 196–210. [Google Scholar]
  32. Petrovic P, Kalso E, Peterson KM, et al. Placebo and opioid analgesia. Imaging a shared neuronal network. Science 2002; 295 : 1737–40. [Google Scholar]
  33. Zubieta JK, Smith YR, Bueller JA, et al. Mu opioid receptor regulation of sensory and affective dimensions of pain. Science 2001; 293 : 311–5. [Google Scholar]
  34. Wager TD, Rilling JK, Smith EE, et al. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science 2004; 303 : 1162–7. [Google Scholar]
  35. Kirsh I, Sapirstein G. Listening to prozac but hearing placebo. A meta-analysis of antidepressants medication. In : Prevention and treatment, vol. 1. New York : American Psychological Association, 1998. journals.apa.org/prevention [Google Scholar]
  36. Leuchter AF, Cook IA, Witte EA, et al. Changes in brain function of depressed subject during treatment with placebo. Am J Psychiatry 2002; 59 : 122–9. [Google Scholar]
  37. Mayberg HS, Silva JA, Brannan SK, et al. The functional anatomy of the placebo effect. Am J Psychiatry 2002; 159 : 728–37. [Google Scholar]
  38. Jonas WB, Katchup TJ, Linde K. A critical review of homeopathy. Ann Intern Med 2003; 138 : 393–459. [Google Scholar]
  39. Rubi P, Decety J. What you believe versus what you think they believe : a neuroimaging study of conceptual perspective-taking. Eur J Neurosci 2004; 17 : 2475–80. [Google Scholar]
  40. Goldapple K, Segal Z, Garson C, et al. Modulation of cortical-limbique pathways in major depression : treatment specific effects of cognitive behaviour therapy. Arch Gen Psychiatry 2004; 61 : 34–41. [Google Scholar]
  41. Wise RA, Rompre PP. Brain dopamine and reward. Ann Rev Psychol 1989; 40 : 191–225. [Google Scholar]
  42. Schultz W. Predictive reward signal of dopamine neurones. J Neurophysiol 1998; 80 : 1–27. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.